Special Interest Satellite Symposium 01: Human Papilloma Virus latency: virological, immunological and clinical aspects:

10:30 AM – 12:00 PM EST (​GMT-5)

Moderator:

P. Gravitt

Presentations:

• Molecular and virological aspects of HPV latency
  J. Doorbar
• Immunological aspects of HPV latency
  M. Stanley
• Clinical and epidemiological aspects of HPV latency
  A. Hammer

Special Interest Satellite Symposium 02: Head and Neck Symposium on HPV: Research and education for HPV elimination:

12:30 AM – 14:00 PM EST (​GMT-5)

Moderator:

S. Pai, C. Derkay

Presentations:

• Recurrent Respiratory Papillomatosis: Introduction of Topic and Speakers
  C. Derkay
• Recurrent Respiratory Papillomatosis: Evidence of the beneficial effects of HPV vaccination on reducing the incidence and prevalence
  P. Campisi
• Recurrent Respiratory Papillomatosis: Strategies for increasing uptake of the HPV vaccine in low and mid-resource countries to prevent RRP
  S. Peer
• Recurrent Respiratory Papillomatosis: Update on treatment of RRP – Surgical advances, adjuvant use and their timing, DNA vaccines
  S. Pransky
• Head and Neck Cancer: Introduction of the Topic and Speaker
  S. Pai
• Can uptake of the HPV vaccine among 27-45-year-old men prevent oropharyngeal cancers in the US?
  R. Landy
• Head and Neck Cancer: Immunotherapies, DNA vaccines, EGFR inhibitors and check-point inhibitors: state-of-the-art treatments of HPV-associated head and neck cancers
  C. Allen
• Head and Neck Cancer: What is different about HPV-associated head and neck cancers?: Diagnosis, Prevention, Education and Prognosis with de-intensified therapies
  B. Haughey
• Question and Answer session
  All Speakers

Special Interest Satellite Symposium 03: Eliminating Cervical Cancer in Canada – from Action Plan to Action:

11:30 AM – 12:30 PM EST (​GMT-5)

Presentations:

• The Action Plan for the elimination of cervical cancer in Canada
  M. Halligan
• Why eliminating cervical cancer matters – lived experience
  C. Howard
• Reaching 90% HPV immunization rate in Canada
  C. Neudorf
• Transitioning to HPV primary screening in Canada
  G. Ogilvie
• Improving access to appropriate follow-up in Canada
  J. Bentley
• Facilitated discussion on elimination of cervical cancer in Canada
  M. Halligan, C. Howard, C. Neudorf, G. Ogilvie, J. Bentley

Special Interest Satellite Symposium 04: Single-dose HPV vaccination: a review of current evidence and future research directions:

18:15 – 19:45 PM EST (​GMT-5)

Moderator:

A. Kreimer

Presentations:

• Evidence review on single-dose HPV vaccination from clinical trials
  D. Watson-Jones
• Observational studies of HPV vaccine effectiveness by number of doses
  L. Markowitz
• Global impact of single-dose HPV vaccination in modelling studies
  K. Prem
• Ongoing trials that directly evaluate single-dose HPV vaccine protection
  A. Kreimer
• Discussion
  All Speakers

Special Interest Satellite Symposium 05: HPV-tests in cervical cancer screening: how will offering a choice of tests improve patient experience and engagement?:

14:00 – 15:00 EST (​GMT-5)

Presentations:

• A Conjoint Analysis of Preferred Characteristics of Self-Sampling for Human Papillomavirus (HPV) Among Low-Income Women
  E. Biederman
• Cervical screening: As you like it
  A. Lim
• Home self-sampling for HPV testing: Are we there yet?
  P. Madhivanan
• The power of women’s autonomy in decision-making on HPV self-sampling in the Peruvian Amazon
  V. Paz-Soldan

Special Interest Satellite Symposium 06: Thinking through the policies: the importance of good communication in HPV testing and vaccination:

On Demand

Moderator:

G. Zimet

Presentations:

• Communicating about cervical cancer screening results in the U.S
  K. Head
• The fall-out of bad communication strategies
  R. Dodd
• Using behavioural science to develop information about policy changes in screening
  L. Marlow
• Responding to an HPV vaccine confidence crisis- experience from Ireland
  L. Jessop

Special Interest Satellite Symposium 07: First Void Urine as a Biomarker Source for Primary and Secondary HPV Related Cancer Prevention:

On Demand

Moderator:

A. Vorsters

Presentations:

• Introduction: Rationale of using first void urine as Biomarker Source of the female Genital Tract
  A. Vorsters
• Impact of HPV vaccination in resource limited settings
  I. Baussano
• Monitoring vaccine induced immune response using first void urine samples
  L. Teblick
• Cervical Cancer screening: Clinical Evaluation of hr.HPV assays using first void urine samples
  S. Van Keer
• Self-sampling for Cervical Screening with Urine or Vaginal Samples
  J. Cuzick

Special Interest Satellite Symposium 07: First Void Urine as a Biomarker Source for Primary and Secondary HPV Related Cancer Prevention:

On Demand

Presentations:

• Welcome
  E. Burger
• Introduction to the CCGMC: scope, aims, work to date, challenges in collating and using registry data
  J. O’Mahony
• Real-world responses to pandemic-related cervical cancer screening disruptions
  M. Elfström
• Cervical screening and the COVID-19 pandemic: the experience of Ireland’s National Screening Service
  C. Mohan
• COVID-19 impact in high-income countries – insights and CCGMC work to date
  M. Smith
• COVID-19 impact on reaching the elimination targets in LMICs – insights and work to date
  K. Simms
• Panel discussion: Lessons learnt, addressing disparities, applications of self-sampling
  

Special Interest Satellite Symposium 09: Elevating the Standard of Care: A Novel Integrated Approach to the Control of Cervical Cancer and Female Genital Schistosomiasis:

On Demand

Moderator:

M. Steben

Presentations:

• Chair Introduction
  M. Steben
• Overview of Female Genital Schistosomiasis and opportunities for prevention
  E. Kjetland
• Cervical cancer screening: an opportunity for impact on FGS (ID 1067)
  Presenter
  M. Schiffman
• Molecular approaches for screening FGS and cervical cancer
  A. Bustinduy
• An integrated approach to cervical cancer and FGS disease control
  Z. Rosberger

Special Interest Satellite Symposium 10: Development of an Automated Visual Evaluation for Cervical Cancer Screening:

On Demand

Moderator:

S. De Sanjose & M. Schiffman

Presentations:

• Introduction to the Symposia: Scope-Moonshot NCI effort on AVE in cervical cancer screening in LMIC
  M. Schiffman
• Key elements of image quality and their impact in AVE performance. Hardware
  D. Levitz
• Main steps in AVE creation: From data sources to algorithms
  B. Befano
• Systematic approach to AVE evaluation
  A. Lemay
• Statistical approaches: AVE score to risk score or how to turn the score into a clinical test
  D. Egemen
• Strategy to evaluate treatability. How AVE can assist patient management
  J. Jeronimo
• Cautionary aspects on the AI application in the clinical settings
  K. Desai
• Next steps: Field evaluation and expected outcomes and closing remarks
  S. De Sanjose

Special Interest Satellite Symposium 11: HPV disease prevention: realities for Indigenous peoples in a COVID19 environment:

On Demand

Moderator:

L. Whop & B. Lawton

Presentations:

• Introduction by the chairs: the Indigenous HPV Alliance
  B. Lawton & L. Whop
• Yarning about HPV and COVID-19 vaccination
  T. Butler
• Managing screening in a COVID19 environment for Māori
  S. Te Whaiti
• HPV self-testing in Samoa
  A. Ekeroma & F. Amosa-Lei Sam
• Pandemic-proof cancer screening: Using HPV self-screening to put cervix health into the hands of Métis communities in Northern British Columbia
  K. Pollard

Special Interest Satellite Symposium 12: Anal cancer and precancerous lesions: what´s new?:

On Demand

Moderator:

A. Grulich

Presentations:

• Anal cancer risk scale
  G. Clifford
• Transplant recipients
  A. Albuquerque
• Women with lower genital neoplasia tract neoplasia
  M. Nathan

Special Interest Satellite Symposium 13: A global standard for monitoring progress towards elimination: fidelity, the cancer continuum, and ensuring sustainable impact:

On Demand

Moderator:

A. Rositch

Presentations:

• Screening coverage, equity, and indicators
  S. Kumar
• Role of policy and working with ministry/national level stakeholders to ensure
  S. Kapambwe

Special Interest Satellite Symposium 14: Key Issues in HPV Cancer Elimination In Europe: Challenges and opportunities:

On Demand

Presentations:

• The HPV Action Network’s priorities and plans
  D. Kelly & R. Medeiros
• Europe’s Beating Cancer Plan – HPV commitments and implementation
  R. Price
• Engaging young people in HPV prevention and advocacy
  J. Crumière
• Tackling vaccine hesitancy: harnessing the power of people’s stories to influence uptake
  J. Daly
• Advocating for change: a single-country case study
  P. Drakos
• Cervical cancer screening in the COVID era: strategies for increasing coverage
  M. Gultekin

Special Interest Satellite Symposium 15: Caught between a Rock and a Hardplace: The US Pacific Island and cervical cancer preventions:

On Demand

Moderator:

M. Saraiya

Presentations:

• Caught between a Rock and a Hard Place
  N. Palafox
• Yap and FSM
  M. Reichhardt
• Background of CDC work with Pacific Islands
  J. Qin
• Behavioral interventions related to recruitment and education
  I. Scarinci
• Screening and Management Algorithms for Guam and Yap
  R. Lu
• Preliminary modelling results on potential benefits of HPV testing if high screening coverage and treatment compliance achieved in Guam and FSM/Yap
  D. Nguyen

Special Interest Satellite Symposium 16: Anogenital and oral HPV infection in men: novel insights from vaccine and modeling studies:

On Demand

Presentations:

• Introduction
  J. Palefsky
• Natural history of anogenital HPV infection and HPV-associated disease: data from the V501-020 study: Baseline serology/infection to nine anogenital HPV types
  S. Goldstone
• Natural history of anogenital HPV infection and HPV-associated disease: data from the V501-020 study: Incidence of anogenital infection/disease in young men
  A. Giuliano
• Natural history of anogenital HPV infection and HPV-associated disease: data from the V501-020 study: Progression of anogenital HPV infection to disease
  J. Palefsky
• Oral HPV infection in men: Modeling natural history of oral HPV infection
  R. Landy
• Oral HPV infection in men: Projecting the impact of HPV vaccination on the incidence of oropharyngeal cancer in the 21st century in the U.S.
  A. Deshmukh
• Oral HPV infection in men: Design of BROADEN and PROGRESS natural history studies
  L. Alemany
• Safety and efficacy of HPV vaccination in men: Summary of 15 years of efficacy data from v501/v503 in men
  Y. Tu
• Safety and efficacy of HPV vaccination in men: Real-world evidence of vaccine effectiveness against oral HPV infection
  L. Alemany
• Safety and efficacy of HPV vaccination in men: Real-world evidence of vaccine effectiveness against oral HPV infection
  L. Alemany
• Closing
  J. Palefsky

Special Interest Satellite Symposium 17: Conquering Cancer Feature Documentary Screening:

On Demand

Presentations:

• Short Movie – Conquering Cancer
  
• Short Movie – Living with HIV/AIDS and Cervical Cancer – Loyce’s Story
  
• Short Movie – Reducing Obstacles to Cervical Cancer Screening – Conquering Cancer
  
• Short Movie – Zambia Elimination Success Story
  
• Panel Discussion
  K. Canfell, M. Saville AM, J. Torode, S. de Sanjose, N. Broutet, S. Kapambwe, L. Kabali